Graviton BioScience
PrivateLast Round
Series B
Feb 14, 2024
Est. Valuation
$255M
Total Funding Raised
$63.5M
Company Overview
Graviton BioScience operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B round in February 2024.
Graviton BioScience is a biotechnology company that discovers and develops innovative small-molecule therapeutics for autoimmune, cancer, fibrotic, and central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Graviton BioScience Comparables
Compare Graviton BioScience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ovid Therapeutics Inc. | 82% | |
| Genosco | 81% | |
| Sino Biopharmaceutical | 78% |
For institutional investors. Book with your work email.
Graviton BioScience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 14, 2024 | ||||
| Series B | Nov 22, 2023 | ||||
| Series A | May 1, 2023 | ||||
| Seed | Feb 19, 2021 |
For institutional investors. Book with your work email.
Graviton BioScience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Enavate Sciences | Series A, Series B |
| Cormorant Asset Management | Series A |
| Pontifax Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors grew 60% MoM, from 1.1K to 1.7K.
- Nov 11, 2025
Monthly visitors grew 41% MoM.
For institutional investors. Book with your work email.
Graviton BioScience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Graviton BioScience's valuation, stock price, and market status.
Is Graviton BioScience a public or private company?
Graviton BioScience is a private company.
What is the current stock price of Graviton BioScience?
Graviton BioScience is a private company, so its shares have no public market price. Caplight tracks Graviton BioScience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Graviton BioScience worth (valuation)?
Graviton BioScience's valuation is estimated at $255.0M based on funding round data.
Can I buy Graviton BioScience stock?
Graviton BioScience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Graviton BioScience's last funding round?
Graviton BioScience's most recent funding round was Series B on February 14, 2024.
Who are the main investors in Graviton BioScience?
Key investors in Graviton BioScience include Enavate Sciences.
Will Graviton BioScience IPO soon?
No public IPO plans have been announced for Graviton BioScience.
How can I track Graviton BioScience secondary market activity?
Caplight tracks bids, offers, and trades in Graviton BioScience's shares on secondary markets.